WallStreetZenWallStreetZen
NASDAQ: AGRX

How to Buy Agile Therapeutics Stock

Open Broker Account

Agile Therapeutics Inc

Agile Therapeutics, Inc. , a women's healthcare company, focuses on the research, development, and commercialization of prescription contraceptive products for women.

Agile Therapeutics stock last closed at $0.28, down 3.07% from the previous day, and has decreased 99.25% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.59 percentage points. Agile Therapeutics stock is currently +8.4% from its 52-week low of $0.26, and -99.31% from its 52-week high of $41.20.

As of Sep 29, 2022, there are 39.02M shares of AGRX outstanding. The market value of AGRX is $11.08M. In the past 24 hours, 689,252 AGRX shares were traded.

How to Buy Agile Therapeutics Stock

Wondering how to invest in Agile Therapeutics stock? Here's how.
  1. Figure out where to buy Agile Therapeutics stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you decide where to buy Agile Therapeutics stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified. It's the best place to buy AGRX stock.
  3. Put funds into your investment account: Pick your payment method and add your information.
  4. Evaluate Agile Therapeutics stock: The Agile Therapeutics ticker symbol is AGRX. Is Agile Therapeutics stock a good investment? Should you buy shares of AGRX? How do AGRX's underlying business fundamentals look? Do top analysts think Agile Therapeutics is a good buy? Why has AGRX's stock price moved recently? (Hint: Our stock research tools can help you figure out if AGRX is a good stock to buy).
  5. Make your AGRX trade: Decide if you will purchase AGRX shares at the current market price or use a limit order to buy AGRX shares at a specific price.
  6. Get notifications regarding your AGRX investment: Create a watchlist to get live updates on your position in Agile Therapeutics stock.

Step 1: Figure out where to buy Agile Therapeutics stock

You will need an online brokerage account to access the NASDAQ market and buy AGRX shares.

A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs, commodities, cryptos, and foreign currencies.

Get $10 towards your your AGRX stock purchase by opening an account with eToro now.

Open eToro Account

Step 2: Sign up for your brokerage account

Now that you've picked the next step is brokerage, picked to fill out some personal details so you are able to buy AGRX today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
  2. Provide your personal info to create your new trading account.
  1. Send your application by hitting the "Create Account" button.
Get started with eToro today

Step 3: Put funds into your investment account

Watch this video walkthrough if you need help depositing funds into your investment account.

Get started with eToro today

Step 4: Evaluate Agile Therapeutics stock

It's crucial to evaluate stocks prior to investing, so you truly wrap your head around the risk as well as the upside.

Agile Therapeutics Metrics

AGRX Price
$0.28
1w %
-6.27%
1y %
-99.25%
5y %
-99.84%
P/E
-0.01x
P/B
3.24x
P/S
0.19x
PEG
N/A
Revenue
$6.69M
Earnings
-$64.12M
Fore. Rev. Growth
89.66%
Fore. Earn. Growth
N/A
Market Cap
$11.08M
Next Earnings
Oct 31, 2022
Next Dividend
N/A

AGRX Due Diligence Checks

WallStreetZen was built to help average investors perform more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on AGRX's stock page.

Is AGRX stock undervalued or overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge AGRX's intrinsic value.

Using relative valuations ratios:

  • AGRX may be overvalued based on its P/B ratio of 3.24x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 1.7x

You can do more valuation research on AGRX's stock here.

How do AGRX Financials look?

Signs that AGRX is financially healthy:

  • There are more short-term assets than long-term liabilities on the AGRX balance sheet.

Signs that AGRX is not financially healthy:

  • AGRX profit margin has gone up by 23.54 percentage points in the past year, but the company is still unprofitable.
  • AGRX has a relatively high debt to equity ratio of 8.6.
  • AGRX has cash burn of 53136000. It does not have sufficient cash and short-term investments to cover this.
  • Total AGRX debt is higher than 5 years ago, relative to shareholder equity.
  • AGRX has $13.03M in cash and short term investments. This is not sufficient to cover its annual cash burn of $53.14M.
  • There are more short-term liabilities than short-term assets on the AGRX balance sheet.

Do Wall Street analysts think it's a good time to buy AGRX stock

Out of 3 Equities analysts who give recommendations on AGRX, the consensus analyst rating on Agile Therapeutics is a Buy

Should I buy or sell AGRX stock?

Based on 3 analysts offering ratings for Agile Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Most Recent AGRX Analyst Upgrades/Downgrades

Naz Rahman, a bottom 4% analyst from Maxim Group upgrades AGRX to a strong buy rating and announces their AGRX price target of $1.00, on Jul 26, 2022.

Oren Livnat, a bottom 3% analyst from HC Wainwright & Co. maintains AGRX with a buy rating and raises their AGRX price target from $2.50 to $5.00, on Jul 11, 2022.

Caroline Palomeque, a bottom 32% analyst from Maxim Group downgrades AGRX to a hold rating, on Apr 8, 2022.

You can dive deeper into what analysts are saying on the Agile Therapeutics stock forecast page.

AGRX Technicals

SMA10
0.32
SMA20
0.35
SMA50
0.46
SMA100
0.82
SMA200
6.39
MACD
-0.06
MACD Signal
-0.06
MACD Histogram
0
RSI
27.14
Stochastic %K
15.06
Stochastic %D
14.06
StochRSI %K
22.93
StochRSI %D
16.65

AGRX Growth Numbers

Last year, AGRX revenue was $6.69M. Over the last 1 years, AGRX's revenue has increased by 226.24% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 94.39%.

You can research AGRX's earnings and revenue performance here.

Are AGRX executives and large shareholders buying or selling the stock?

In the last year, executives and large shareholders at AGRX have bought more shares than they have sold.

Alfred Altomari, Chief Executive Officer of AGRX, was the latest AGRX insider to buy. They bought $22,500.00 worth of AGRX stock on Aug 26, 2022.

Get more info about who owns AGRX shares here.

Does AGRX provide a stable income stream?

No, Agile Therapeutics doesn't provide an income stream by paying out dividends.

AGRX Social Trading Data

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your AGRX trade

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.

Press the Open button and your broker will execute your order.

If you need more help with investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get notifications regarding your AGRX investment

Now that you own some AGRX shares, you'll want to keep up with your new investment.

Make a watchlist to get notified of the latest news about your AGRX stock.

AGRX Feed

How to Buy Stock in Agile Therapeutics

To summarize, here are the 6 steps you need to take to buy Agile Therapeutics stock right now:

  1. Figure out where to buy Agile Therapeutics stock
  2. Sign up for your brokerage account
  3. Put funds into your investment account
  4. Evaluate Agile Therapeutics stock
  5. Make your AGRX trade
  6. Get notifications regarding your AGRX investment

If you require a online brokerage, eToro is our favorite venue.

Get Started with eToro Today

If you want to get notifications regarding your investment in Agile Therapeutics, create your watchlist below.

NASDAQ: AGRX
$0.28-0.01 (-3.07%)
Updated Sep 29, 2022
Open eToro Account
NASDAQ: AGRX
$0.28-0.01 (-3.07%)
Updated Sep 29, 2022
Open eToro Account

FAQ

How much does it cost to buy one Agile Therapeutics share?

As of Sep 29, 2022, it costs $0.28 to buy one share of Agile Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.14, you can buy 0.5 shares of AGRX.

Get Started with eToro Today

Is now a good time to buy Agile Therapeutics stock?

According to 3 Wall Street analysts who monitor Agile Therapeutics, their consensus recommendation is to buy Agile Therapeutics stock.

What is the best way to buy Agile Therapeutics stock?

The best way to buy Agile Therapeutics stock is within a brokerage account on eToro.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.